関連する実験動画
Updated: Sep 10, 2025

03:25
Simple Continuous Glucose Monitoring in Freely Moving Mice
Published on: February 24, 2023
6.0K
夜間低血糖症:現実世界の環境における継続的なグルコースモニタリングによる特徴付け
Michael Mitter1, Delphine Theodorou2, Bernhard Ruch1
1Digital Biomarker Data Insights, mySugr GmbH, Vienna, Austria.
Diabetes technology & therapeutics
|August 25, 2025
まとめ
夜間低血糖症は 頻度が低いものの,長続きし,糖尿病患者では翌日の血糖コントロールに 顕著な影響を及ぼします. 長期にわたる夜間低血糖の管理には 改善された予防策が必要です
科学分野:
- 内分泌学
- 代謝 疾患
- 糖尿病 管理
背景:
- 夜間低血糖症は,糖尿病の管理における頻繁な合併症です.
- 継続的な血糖モニタリング (CGM) のデータは,特に2型糖尿病 (T2D) の夜間低血糖症を過小評価する.
- 夜間の低血糖症の持続時間と昼間の影響については,理解は限られている.
研究 の 目的:
- 1型糖尿病 (T1D) と2型糖尿病患者の夜間低血糖症と昼間低血糖症の頻度と期間を比較する.
- 夜間の低血糖症が,その後の昼間のグルコースプロファイルに与える影響を評価する.
- 夜間低血糖症の予防策の必要性を強調する.
主な方法:
- T1D患者3696人とT2D患者441人のCGMデータを遡って分析した.
- 低血糖現象はCGMの値 <70 mg/dLまたは<54 mg/dLを≥15分間と定義する.
- 夜間の低血糖症と昼間の低血糖症の発生率,持続時間,翌日の影響の比較
主要な成果:
- 夜間低血糖症は頻度が低かったが,昼間症状 (T1Dでは65分,T2Dでは57分) に比べて平均持続時間が長かった.
- 昼間の血糖値の有意な変化が,夜間低血糖症の後に観察され,朝の低血糖症のリスクが増加したことを示した.
- これらの発見はT1DとT2Dの2つの集団で一致しました.
結論:
- 夜間の低血糖症は,昼間の低血糖症よりも長く回復することが特徴です.
- 夜間低血糖症は翌日の血糖値に大きく影響し,朝の低血糖症のリスクを高めます.
- 糖尿病の治療における夜間低血糖症の予防と管理のための戦略の改善が不可欠です.
関連する概念動画
Hypoglycemia and Glucagon
334
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
334
Glucose Homeostasis: Regulation of Blood Glucose
2.5K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
2.5K
Hormones Regulating Blood Glucose
4.0K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
4.0K
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Oral Hypoglycemic Agents: Glinides
257
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
257
Diabetes Mellitus: Overview and Type I Subtype
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K

